We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Status: Active

Jun 22nd 2020 - Jul 25th 2020

Gendius is a company that aims to bring pharmaceuticals and health economics, through clinical research and evidence, to the mobile health market. Their latest innovation, Intellin, is an intelligent remote management diabetes platform, with over 140,000 downloads so far. The COVID-19 crisis has highlighted the need for remote home monitoring of patients, and the company feels that its product is a suitable contender in this domain. Intellin has a reliable connection to over 150 medical devices and apps, and also consists of a two-way communication setup with a healthcare professional via a secure dashboard. Gendius is registered as an approved vendor with AstraZeneca in Saudi Arabia and looks to establish deeper relations with the National Health Service (UK) to create a demand for its product. The company will use the investment to scale its business globally, drive commercialisation, offer an opportunity to its stakeholders, and target venture capital.

read more read less

Gendius Rating Review

Rated on 30/06/2020

Pitch Rated









Pitch rating powered by CROWDRATING

What the ratings mean

  • 49% and under
    We suggest potential investors carry out further study of their own
    Room for improvement
    Worth considering
    Gold rating, our highest rating
Click here for more information on our ratings
Login to view the full report

Management 90%

Skills 91%
Gendius has a skilled and diverse team in place covering the roles of management, platform development, and marketing and finance. The CEO is successful in creating and selling profitable businesses from start-ups. He brings skills of starting up businesses, successful market access, driving profit before tax, setting brand strategy and objectives, developing and motivating organisations as well as liaising with global business units. The Co-founder is an experienced Sales Director within the Pharmaceutical Industry having expertise in pharmaceuticals sales, product launch, and market access. The Lead Developer is a full-stack web and mobile developer with coding and technical skills. Sales and Marketing are run by a marketer along with various PR and Marketing Agencies. Her specialities include brand design and experience, events management, visual merchandising, product promotion, trend prediction, public relations, advertising, online journalism, and copywriting. The Chairman of the company is proficient in the fields of med-tech, life sciences, social impact, startups, funding, and health and wellness. Operating at a pre-profit stage and planning to raise £5 million in the near future.


Log in to comment

Funding progress

More from Health and Fitness

BLOK is a multi-disciplinary studio and digital fitness platform. The company's first site in Clapton, Hackney opened in Q1 of 2016, followed by Shoreditch in 2018, and Manchester in 2019. In May 2020, BLOK launched BLOKtv. This launch led to nearly 2,000 people joining BLOK's classes each week with more customers joining in from 134 countries. The digital fitness market has experienced an annual growth of 33% since 2017, and BLOK aims to be the market leader in this segment. The company has hosted global stars such as Anthony Joshua, Jourdan Dunn, Kayla Itsines, Conor Benn and Alicia Vikander. BLOK's studios have also featured on programmes such as 'Britain's Next Top Model' and 'Made in Chelsea'. The company raised over £891,000 from 571 investors on Crowdcube in 2018. It will use the investment to accelerate the growth of BLOKtv and further build its digital community.
pledged: 160% days to go: 12 investment: £402,475
OnCare is a digital care management software that is digitising elderly care, creating a global care marketplace via the OpenTable model to care. OnCare provides care agencies with the power to plan, manage and enhance care delivery and staff communication. Their mission is to make care easier for everyone. OnCare is currently live with over 110 home-care agencies around the UK, and more than 1100 care workers. The company is planning to enter markets of Hong Kong, Canada and Israel. With the proceeds, the company will use this fund for people, office space, technology, software, hosting and marketing.

Pitch Rated



rating powered by


pledged: 64% days to go: 18 investment: £96,040

  • £386,829
  • 773%
    of goal


    pre-money valuation

    equity available


    pledge per investor

    company number

    company status

    incorporated 7 years

    share price

    Equity Calculator
    Previous Funding rounds
    22 Jun 20 Crowdcube £386,829 / 774% 83.67%
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph